These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 3146584)
1. Neutralizing antibodies as a prognostic indicator in the progression of acquired immune deficiency syndrome (AIDS)-related disorders: a double-blind study. Sei Y; Tsang PH; Roboz JP; Sarin PS; Wallace JI; Bekesi JG J Clin Immunol; 1988 Nov; 8(6):464-72. PubMed ID: 3146584 [TBL] [Abstract][Full Text] [Related]
2. The affinity of IgG antibodies to gag p24 and p17 in HIV-1-infected patients correlates with disease progression. Chargelegue D; Stanley CM; O'Toole CM; Colvin BT; Steward MW Clin Exp Immunol; 1995 Feb; 99(2):175-81. PubMed ID: 7851008 [TBL] [Abstract][Full Text] [Related]
3. Fine specificity of IgG subclass response to group antigens in HIV-1-infected patients. Broliden PA; Morfeldt-Månsson L; Rosen J; Jondal M; Wahren B Clin Exp Immunol; 1989 May; 76(2):216-21. PubMed ID: 2503275 [TBL] [Abstract][Full Text] [Related]
4. Monitoring human immunodeficiency virus type 1-infected patients by ratio of antibodies to gp41 and p24. Schmidt G; Amiraian K; Frey H; Wethers J; Stevens RW; Berns DS J Clin Microbiol; 1989 May; 27(5):843-8. PubMed ID: 2501350 [TBL] [Abstract][Full Text] [Related]
5. Prevalence and persistence of antibody titers to recombinant HIV-1 core and matrix proteins in HIV-1 infection. Janvier B; Mallet F; Cheynet V; Dalbon P; Vernet G; Besnier JM; Choutet P; Goudeau A; Mandrand B; Barin F J Acquir Immune Defic Syndr (1988); 1993 Aug; 6(8):898-903. PubMed ID: 8315575 [TBL] [Abstract][Full Text] [Related]
6. Specific antibody responses to synthetic peptides of HIV-1 p17 correlate with different stages of HIV-1 infection. Jiang JD; Chu FN; Naylor PH; Kirkley JE; Mandeli J; Wallace JI; Sarin PS; Goldstein AL; Holland JF; Bekesi JG J Acquir Immune Defic Syndr (1988); 1992; 5(4):382-90. PubMed ID: 1372353 [TBL] [Abstract][Full Text] [Related]
7. Association of human immunodeficiency virus (HIV) p24 antigenemia with decrease in CD4+ lymphocytes and onset of acquired immunodeficiency syndrome during the early phase of HIV infection. Rinaldo C; Kingsley L; Neumann J; Reed D; Gupta P; Lyter D J Clin Microbiol; 1989 May; 27(5):880-4. PubMed ID: 2501352 [TBL] [Abstract][Full Text] [Related]
8. HIV-1 neutralizing antibodies in urine from seropositive individuals. Cao YZ; Friedman-Kien AE; Mirabile M; Li XL; Alam M; Dieterich D; Ho DD J Acquir Immune Defic Syndr (1988); 1990; 3(3):195-9. PubMed ID: 1968094 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of antibodies to the core protein P17, a serological marker during HIV-1 infection. Mehta SU; Rupprecht KR; Hunt JC; Kramer DE; McRae BJ; Allen RG; Dawson GJ; Devare SG AIDS Res Hum Retroviruses; 1990 Apr; 6(4):443-54. PubMed ID: 1692727 [TBL] [Abstract][Full Text] [Related]
10. An ELISA-inhibition assay for antibody to human immunodeficiency virus core antigen (p24). Povolotsky J; Gold JW; Darminin P; Chein N; Baron P; Armstrong D J Virol Methods; 1990 Oct; 30(1):109-14. PubMed ID: 2128300 [TBL] [Abstract][Full Text] [Related]
11. [Dynamics of the antibody response and p24 antigenemia in HIV-1 infected individuals in Czechoslovakia]. Kopecká D; Brůcková M; Stanková M; Syrůcek L; Vojtĕchovský K; Petkov V Cesk Epidemiol Mikrobiol Imunol; 1990 Mar; 39(2):65-73. PubMed ID: 2142624 [TBL] [Abstract][Full Text] [Related]
12. A 7-year analysis of anti-Gag (p17 and p24) antibodies in HIV-1-seropositive patients with haemophilia: immunoglobulin G titre and avidity are early predictors of clinical course. Chargelegue D; Colvin BT; O'Toole CM AIDS; 1993 Nov; 7 Suppl 2():S87-90. PubMed ID: 7909231 [TBL] [Abstract][Full Text] [Related]
13. Reliable confirmation of antibodies to human immunodeficiency virus type 1 (HIV-1) with an enzyme-linked immunoassay using recombinant antigens derived from the HIV-1 gag, pol, and env genes. Ng VL; Chiang CS; Debouck C; McGrath MS; Grove TH; Mills J J Clin Microbiol; 1989 May; 27(5):977-82. PubMed ID: 2787334 [TBL] [Abstract][Full Text] [Related]
14. Decline of antibody reactivity to outer viral core protein p17 is an earlier serological marker of disease progression in human immunodeficiency virus infection than anti-p24 decline. Lange JM; de Wolf F; Krone WJ; Danner SA; Coutinho RA; Goudsmit J AIDS; 1987 Sep; 1(3):155-9. PubMed ID: 3126756 [TBL] [Abstract][Full Text] [Related]
15. Inverse relationship between HIV-1 p24 antigenemia, anti-p24 antibody and neutralizing antibody response in all stages of HIV-1 infection. Sei Y; Tsang PH; Chu FN; Wallace I; Roboz JP; Sarin PS; Bekesi JG Immunol Lett; 1989 Feb; 20(3):223-30. PubMed ID: 2497067 [TBL] [Abstract][Full Text] [Related]
16. Antibodies against the major core protein p24 of human immunodeficiency virus: relation to immunological, clinical and prognostic findings. Lindhardt BO; Gerstoft J; Hofmann B; Pallesen G; Mathiesen L; Dickmeiss E; Ulrich K Eur J Clin Microbiol Infect Dis; 1989 Jul; 8(7):614-9. PubMed ID: 2506021 [TBL] [Abstract][Full Text] [Related]
17. Detection of serum HIV-Ag related to the major core protein (p24) in persons at risk for AIDS. Borghi V; De Rienzo B; Pietrosemoli P; Pecorari M; Mongiardo N; Pellegrino F; Zanchetta GP; Lami G; Squadrini F Microbiologica; 1989 Jan; 12(1):81-3. PubMed ID: 2497304 [TBL] [Abstract][Full Text] [Related]
18. A prospective study on correlation between the decrease in anti-P17 antibody level and progression to AIDS in asymptomatic carriers of HIV. Choudhury AM; Yamada O; Wakamiya N; Kurimura T Microbiol Immunol; 1992; 36(8):833-40. PubMed ID: 1474934 [TBL] [Abstract][Full Text] [Related]
19. Clinical and biological features in the 12 months preceding onset of AIDS in HIV-infected subjects. Lefrere JJ; Courouce AM; Lambin P; Fine JM; Doinel C; Salmon C J Acquir Immune Defic Syndr (1988); 1989; 2(1):100-1. PubMed ID: 2493092 [TBL] [Abstract][Full Text] [Related]